Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC2A1 | P11166 | 15/20 | 0.36 |
| ▸ | SLC2A3 | P11169 | 15/20 | 0.36 |
| ▸ | SLC2A4 | P14672 | 15/20 | 0.36 |
| ▸ | SLC2A2 | P11168 | 5/20 | 0.36 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.34 |
| ▸ | HRH2 | P25021 | 1/20 | 0.34 |
| ▸ | HRH1 | P35367 | 1/20 | 0.34 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.34 |
| ▸ | PPARG | P37231 | 1/20 | 0.33 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.33 |
| ▸ | GPR6 | P46095 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12113086 | 0.93 | KMT2A (0.34) | SLC2A1SLC2A3SLC2A4SLC2A2PPARG | |
| SCHEMBL12113110 | 0.92 | SLC2A1 (0.36) | SLC2A1SLC2A3SLC2A4SLC2A2 | |
| SCHEMBL12113072 | 0.91 | CHRNA7 (0.34) | CHRNA7 | |
| SCHEMBL12113124 | 0.91 | SLC2A1 (0.36) | SLC2A1SLC2A3SLC2A4SLC2A2 | |
| SCHEMBL12113078 | 0.89 | SLC2A1 (0.35) | SLC2A1SLC2A3SLC2A4SLC2A2ADORA3 | |
| SCHEMBL12117045 | 0.88 | SLC2A1 (0.41) | SLC2A1SLC2A3SLC2A4SLC2A2 | |
| SCHEMBL12112989 | 0.88 | PPARG (0.37) | SLC2A1SLC2A3SLC2A4SLC2A2PPARG | |
| SCHEMBL12113127 | 0.88 | DHODH (0.34) | SLC2A1SLC2A3SLC2A4SLC2A2PPARG | |
| SCHEMBL12112961 | 0.85 | PPARG (0.36) | SLC2A1SLC2A3SLC2A4PPARGCHRNA7 | |
| SCHEMBL12113190 | 0.85 | CACNA1H (0.37) | SLC2A1SLC2A3SLC2A4SLC2A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8536202-B2 | Triazole-substituted anthranilamides as pesticides | BAYER CROPSCIENCE AG (DE) | 2013-09-17 | — | — | US | disclosed |
| US-8536202-B2 | Triazole-substituted anthranilamides as pesticides | BAYER CROPSCIENCE AG (DE) | 2013-09-17 | — | — | US | disclosed |
| US-20110275676-A1 | Triazole-substituted anthranilamides as pesticides | BAYER CROPSCIENCE AG (DE) | 2011-11-10 | — | — | US | disclosed |
| US-20110275676-A1 | Triazole-substituted anthranilamides as pesticides | BAYER CROPSCIENCE AG (DE) | 2011-11-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110275676-A1 | Triazole-substituted anthranilamides as pesticides | AADAC, NAAA, ANTXR2 | SLC2A1 4803/4885SLC2A3 4685/4885SLC2A4 4817/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.